Beyond Two Pills: My Journey to Uncover the Single System Behind Anxiety and High Blood Pressure—And How to Truly Treat It

Part 1: The Revolving Door of Frustration—My Search for a Flawed Answer

As a medical researcher specializing in psychopharmacology and cardiovascular health, I spent the early part of my career steeped in the conventional wisdom of my fields.

The protocols were clear, the diagnostic manuals were my guide, and the treatment algorithms seemed logical.

We had a pill for the mind and a pill for the body.

The problem was, for a distressingly large number of people, this siloed approach wasn’t just failing—it was actively making things worse.

This reality became painfully clear to me through the case of a patient I’ll call “Mark.”

Mark, a man in his late 40s, came to his primary care physician with a classic presentation.

He was consumed by a persistent, free-floating worry that had begun to interfere with his work and family life—a textbook case of Generalized Anxiety Disorder (GAD).¹

During his workup, his blood pressure was consistently elevated, leading to a concurrent diagnosis of Stage 1 hypertension.²

He was, in essence, a walking embodiment of one of modern medicine’s most common comorbidities.

The National Institutes of Health estimates that nearly one-third of American adults will experience an anxiety disorder at some point, and nearly half have hypertension.²

Mark was at the heart of the storm.

Following established guidelines, Mark’s journey through the healthcare system began.

He was referred to a psychiatrist who, quite reasonably, initiated treatment with a first-line medication for GAD: a serotonin-norepinephrine reuptake inhibitor, or SNRI.⁴

These drugs, like venlafaxine (Effexor) or duloxetine (Cymbalta), are widely prescribed and often effective.⁵

And for Mark, there was some initial relief.

The constant hum of his anxiety quieted slightly.

But a new, more insidious problem began to emerge.

At his follow-up appointments, his blood pressure, which had been a concern, was now a significant problem.

It was climbing steadily, pushing him into more dangerous territory.

The Iatrogenic Loop: When Cures Collide

What was happening to Mark was not a mystery if you looked closely at the pharmacology, but it was a disaster from a patient’s perspective.

He was caught in what I came to call an “iatrogenic loop”—a vicious cycle where the treatment for one condition directly worsens another, prompting a new treatment that carries its own risks.

The first part of the loop was the anxiety medication itself.

SNRIs work by increasing the brain’s levels of two key neurotransmitters: serotonin and norepinephrine.⁷

While this can be beneficial for mood and focus, norepinephrine is also the primary chemical messenger of the sympathetic nervous system—the body’s “fight-or-flight” engine.⁸

Bouts of anxiety are known to cause temporary spikes in blood pressure precisely because they trigger this system.⁹

By prescribing a medication that chronically increased the availability of norepinephrine, we were essentially putting a foot on the accelerator of Mark’s stress response system.

It’s a known potential side effect; some antidepressants, particularly SNRIs and tricyclics, can raise blood pressure.¹¹

For Mark, this side effect wasn’t minor; it was a clinically significant worsening of his cardiovascular disease.

This led to the second part of the loop.

With his blood pressure now consistently high, Mark was referred to a cardiologist.

The cardiologist, also following standard guidelines, prescribed one of the most common treatments for hypertension: a beta-blocker.¹⁴

This medication would work to counteract the effects of the norepinephrine, slowing his heart rate and lowering his blood pressure.

Problem solved, right?

Not quite.

Here, the loop closed in on itself.

While beta-blockers are effective for hypertension, they and another class of blood pressure drugs called calcium channel blockers have been associated with an increased risk of mood disorders, including depression.¹⁶

A large cohort study published in the journal

Hypertension found that patients taking beta-blockers or calcium antagonists had double the risk of hospital admission for a mood disorder compared to those taking other types of blood pressure medication.¹⁶

Some studies have even found that beta-blockers can cause depressive features, particularly those that are more “lipophilic” and can cross the blood-brain barrier more easily, like propranolol.¹⁸

Mark was trapped.

The pill for his mind was harming his cardiovascular system, and the pill for his body carried a significant risk of worsening his underlying mental health condition.

His life became a frustrating cycle of specialist appointments, medication adjustments, and a growing sense of despair.

He was following all the rules, and so were his doctors, but his overall health was deteriorating.

This wasn’t a failure of a single drug; it was a failure of the entire system of thought that treated his anxious mind and his hypertensive body as two separate, unrelated entities.

It was this profound disconnect that sent me searching for a better framework, a new paradigm that could explain and, hopefully, resolve the paradox that was trapping patients like Mark.

Part 2: The Epiphany—It’s Not Two Problems, It’s One Broken System

The frustration I felt watching cases like Mark’s unfold pushed me to look beyond the siloed worlds of psychopharmacology and cardiology.

The answer, I was beginning to suspect, wasn’t in finding a better pill for anxiety or a better pill for hypertension.

The answer had to lie in understanding why these two conditions were so intimately, destructively intertwined.

My search led me to a seemingly unrelated field: systems theory.

And it was there, in the simple, elegant concept of feedback loops, that I found the epiphany that would change my entire approach to medicine.¹⁹

The “Aha” Moment: An Analogy from an Unrelated Field

The key insight came from a powerful analogy: the body’s master regulatory network, the Autonomic Nervous System (ANS), functions just like a home’s heating, ventilation, and air conditioning (HVAC) system, complete with a central thermostat.¹⁹

This system is designed to maintain a stable internal environment, a state scientists call homeostasis.

It operates automatically, in the background, managing everything from our heart rate and breathing to our digestion and body temperature.²⁰

The ANS has two main branches, which can be understood through the HVAC analogy:

• The Sympathetic Nervous System (SNS) is the “Heater and Air Conditioner.” This is the active, energy-burning component. It is the famous “fight-or-flight” system.⁸ When you perceive a threat—whether it’s a real danger or a stressful work deadline—the SNS kicks on. It floods your system with hormones like adrenaline and norepinephrine, increasing your heart rate, raising your blood pressure, and diverting blood to your muscles so you can respond to the challenge.¹ It’s the system that turns the furnace on high when the house gets cold.
• The Parasympathetic Nervous System (PNS) is the “Idle Mode.” This is the “rest-and-digest” system. When the threat has passed, the PNS takes over to calm things down. It slows the heart rate, lowers blood pressure, and redirects energy to long-term projects like digestion, immune function, and cellular repair.²² It’s the state the HVAC system returns to when the room has reached its target temperature—quiet, stable, and energy-efficient.

A healthy, resilient person has a well-calibrated “thermostat.” Their SNS activates appropriately in response to stress, but once the stressor is gone, their PNS efficiently brings the system back to a calm baseline.

Reframing the Problem: A Stuck Thermostat

With this new framework, the connection between anxiety and hypertension snapped into focus.

They weren’t two separate diseases; they were two different symptoms of the exact same underlying problem: a broken thermostat.

Or, more accurately, a thermostat stuck in the “on” position.

• Chronic anxiety is the feeling of the heater being stuck on full blast. Even when there is no real danger, the SNS is in a state of constant, high-alert activation. The mind experiences this as worry, racing thoughts, and a pervasive sense of dread. The body experiences it as a racing heart, muscle tension, and rapid breathing.¹
• Essential hypertension is the physical consequence of the heater being stuck on. It’s the high energy bill, the constant noise, the wear and tear on the furnace and ductwork. Years of the SNS running in overdrive, without the balancing influence of the PNS, damages the arteries, forces the heart to work harder, and leads to chronically elevated blood pressure.²⁴

This state of imbalance—of chronic sympathetic overdrive and parasympathetic under-activation—is a recognized medical condition known as dysautonomia, or autonomic dysfunction.²⁰

Research has increasingly pointed to this very imbalance as the core pathophysiological mechanism behind essential hypertension.²³

Studies show that even in the early stages of hypertension, individuals exhibit signs of an overactive sympathetic system and a weakened parasympathetic (or vagal) tone.²⁵

Furthermore, research has identified anxiety as a more significant psychological driver of this imbalance than even depression, finding direct correlations between trait anxiety and a dysfunctional sympatho/vagal balance in hypertensive patients.²⁷

This was the paradigm shift.

The goal could no longer be to separately treat the feeling of anxiety and the measurement of high blood pressure.

The true therapeutic target had to be the single, underlying broken system: the dysregulated Autonomic Nervous System.

The question was no longer, “What two pills should Mark take?” The question became, “What interventions—pharmacological, behavioral, or otherwise—can help us fix Mark’s broken thermostat?” This new question opened up a world of possibilities and provided a unified theory that could finally make sense of the patient’s lived experience.

Part 3: A Systems-Based Guide to Medication: Targeting the Master Regulator

Once we reframe the problem from treating two separate diseases to recalibrating one underlying system—the Autonomic Nervous System—our entire approach to medication changes.

We are no longer just trying to mask symptoms; we are trying to strategically intervene in the body’s master regulatory network.

This perspective allows us to evaluate medications not just on their primary effect but on their total impact on the body’s “thermostat.” It helps us choose tools that work in harmony, rather than at cross-purposes.

Subsection 3.1: The “Volume Knobs”—Beta-Blockers

Beta-blockers, such as propranolol (Inderal), atenolol (Tenormin), and metoprolol (Lopressor), are a fascinating class of drugs when viewed through the ANS lens.

Using our HVAC analogy, they don’t fix the faulty signal from the thermostat that’s telling the furnace to run constantly.

Instead, they act like a volume knob on the furnace itself.

They work by blocking the beta-adrenergic receptors where the stress hormones adrenaline (epinephrine) and noradrenaline (norepinephrine) exert their effects.⁸

By blocking these receptors on the heart and in blood vessels, they prevent the heart from racing and help keep blood pressure from soaring, even when the SNS is sending “panic” signals.²⁸

This mechanism makes beta-blockers uniquely suited for treating the physical manifestations of anxiety.

For someone suffering from performance anxiety—stage fright, fear of public speaking, or even an important job interview—a beta-blocker can be remarkably effective.³¹

It can quell the racing heart, stop the hands from trembling, and keep the voice steady, all without causing the sedation or “brain fog” associated with other fast-acting anxiety medications like benzodiazepines.³¹

They are fast-acting, typically working within 20 to 30 minutes, and non-habit-forming, making them a popular choice for occasional, situational use.³¹

However, their limitations are a direct result of their mechanism.

Because they only turn down the “volume” of the physical response, they do nothing to address the psychological source of the anxiety—the racing thoughts, the worry, the fear.³³

This is why they are not a first-line treatment for chronic conditions like GAD.

The risks associated with beta-blockers also stem from their systemic effects.

They are generally not recommended for individuals with asthma, as they can trigger severe attacks.¹⁵

They must be used with caution in people with diabetes because they can mask the symptoms of low blood sugar, such as a rapid heartbeat.¹⁵

A personal account from a student named Rachel, who used propranolol for severe exam stress, perfectly illustrates this double-edged sword.

The medication calmed her physical panic, but as someone with naturally low blood pressure, she had to be careful to avoid side effects like light-headedness and fainting.³⁵

Other common side effects include fatigue, dizziness, and cold hands or feet, which are all logical consequences of turning down the body’s circulatory “volume”.¹⁵

Subsection 3.2: The “Specialized Wiring”—Alpha-Blockers

If beta-blockers are the volume knob on the furnace, alpha-blockers like prazosin (Minipress) and doxazosin (Cardura) act on a different part of the system’s “specialized wiring.” They primarily block alpha-1 adrenergic receptors, which are found on the smooth muscle of blood vessel walls.³⁶

Blocking these receptors causes the blood vessels to relax and widen, lowering blood pressure.³⁷

It is crucial to understand that alpha-blockers are not a first-line treatment for hypertension.

A major clinical trial (the ALLHAT trial) was stopped early because it found that patients treated with the alpha-blocker doxazosin had a significantly higher risk of developing heart failure compared to those treated with a simple diuretic.³⁹

Their use in hypertension is now generally reserved for cases where other medications haven’t worked or are contraindicated.³⁷

Their relevance in our discussion of the ANS comes from a very specific and important off-label use: the treatment of PTSD-related nightmares with prazosin.⁴⁰

PTSD is a condition of extreme sympathetic overdrive, and these terrifying nightmares are a manifestation of that over-activation during sleep.

Prazosin, by blocking some of these sympathetic signals in the brain, can reduce the frequency and intensity of these nightmares.

This highlights their role as a highly specialized tool for targeting a specific symptom of severe ANS dysregulation, rather than a general treatment for anxiety or hypertension.

The risks associated with alpha-blockers are significant and directly related to their potent effect on blood vessels.

They are notorious for causing a “first-dose effect,” a sudden and dramatic drop in blood pressure when standing up (orthostatic hypotension), which can lead to dizziness and fainting.³⁶

This risk is particularly high in older adults and makes them a class of medication to be used with extreme caution.³⁹

Subsection 3.3: The “Mood-Friendly” Pressure Valves—ACE Inhibitors and ARBs

Angiotensin-converting enzyme (ACE) inhibitors, such as lisinopril, and angiotensin II receptor blockers (ARBs), such as losartan, represent a pivotal strategic choice for patients with both anxiety and hypertension.

While their primary mechanism involves a different hormonal pathway—the renin-angiotensin system—their downstream effects and, most importantly, their side effect profile make them highly relevant to our ANS-focused approach.¹⁴

The critical insight here comes from the large-scale studies on the psychiatric side effects of blood pressure medications.

As mentioned, beta-blockers and calcium channel blockers have been linked to an increased risk of depression.¹⁶

In stark contrast, the same research suggests that

ACE inhibitors and ARBs may actually decrease the risk of developing mood disorders.¹⁶

While the exact mechanism for this protective effect is still being explored, the clinical implication is profound.

For a patient like Mark, who presents with both anxiety and hypertension, starting with an ACE inhibitor or an ARB for his blood pressure is a strategically superior choice.

It effectively treats the hypertension without carrying the risk of worsening his underlying psychiatric condition.

In fact, it may even offer a degree of mood protection.

This simple choice can prevent the entire iatrogenic loop from ever starting.

It is a prime example of how thinking about the patient as a single, integrated system—rather than a collection of separate problems—leads to safer and more effective treatment decisions.

Subsection 3.4: Navigating Antidepressants with an Eye on the “Thermostat”

When selecting an antidepressant for a patient with co-occurring hypertension, the ANS paradigm demands we ask a simple question: “Will this medication turn the ‘thermostat’ up or down?”

• Selective Serotonin Reuptake Inhibitors (SSRIs): Drugs like sertraline (Zoloft) and escitalopram (Lexapro) are the true first-line medication treatments for GAD, panic disorder, and other anxiety conditions.⁵ They work primarily by increasing the availability of serotonin. While serotonin can have a mild effect on blood vessels, SSRIs are generally much less likely to directly activate the sympathetic nervous system and raise blood pressure compared to other classes of antidepressants.¹³ They are the safer “default” choice for a patient with cardiovascular concerns.
• Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): As we saw with Mark, drugs like venlafaxine (Effexor) and duloxetine (Cymbalta) increase both serotonin and norepinephrine.⁷ That norepinephrine component means they can directly “turn up the heat” on the sympathetic nervous system, increasing heart rate and blood pressure.⁹ While they can be very effective antidepressants, this makes them a riskier choice for someone with pre-existing or borderline hypertension. The decision to use an SNRI in such a patient requires careful consideration and diligent blood pressure monitoring.

A Systems-Based Medication Strategy

This analysis reveals that the “best” medication is not a single drug but a thoughtful strategy.

It involves selecting agents that either directly help to calm the overactive sympathetic system or, at a minimum, do not further activate it.

For a patient with both anxiety and hypertension, a combination of an SSRI (less likely to increase sympathetic drive) and an ACE inhibitor (less likely to cause depression) represents a far more synergistic and safer starting point than the conventional but potentially conflicting combination of an SNRI and a beta-blocker.

This is the power of the systems-based approach: it provides a clear, evidence-based rationale for making smarter, more holistic prescribing decisions.

Medication Class	Common Examples	Primary Effect on ANS (“Thermostat”)	Best For…	Key Risks & Considerations
Beta-Blockers	Propranolol, Atenolol, Metoprolol	Turns down the “volume” of the SNS response; blocks adrenaline’s effects on the heart. Does not change the central “thermostat” setting.	Situational/performance anxiety (physical symptoms like racing heart, tremors). Second-line for hypertension.	Does not treat psychological anxiety (worry). Contraindicated in asthma. Caution in diabetes. Can cause fatigue, dizziness, cold extremities, and potentially mood changes.15
SSRIs	Sertraline (Zoloft), Escitalopram (Lexapro)	Primarily affects serotonin; minimal direct effect on the SNS “thermostat.” Generally neutral to calming.	First-line treatment for chronic anxiety disorders (GAD, Panic Disorder, SAD).	Takes 4-6 weeks to work. Can cause initial jitteriness, nausea, headache, and sexual side effects. Less likely to raise BP than SNRIs, but monitoring is still needed.5
SNRIs	Venlafaxine (Effexor), Duloxetine (Cymbalta)	Increases both serotonin and norepinephrine. Can “turn up the heat” on the SNS thermostat.	Effective for anxiety and depression, sometimes used when SSRIs fail.	Known risk of increasing blood pressure and heart rate. Requires careful BP monitoring, especially in patients with pre-existing hypertension.9
ACE Inhibitors / ARBs	Lisinopril (ACE-I), Losartan (ARB)	Primarily acts on the renin-angiotensin system, but has a favorable interaction with the ANS.	First-line treatment for hypertension, especially in patients with diabetes or kidney disease. A strategic choice for hypertensive patients with anxiety/depression.	May be associated with a decreased risk of mood disorders. Main side effect of ACE-I is a dry cough. Generally well-tolerated.14
Alpha-Blockers	Prazosin, Doxazosin	Blocks alpha-receptors on blood vessels, causing relaxation. A specialized tool for specific SNS symptoms.	Not first-line for hypertension. Prazosin is used off-label for PTSD-related nightmares.	High risk of “first-dose” orthostatic hypotension (dizziness, fainting). Long-term use linked to increased heart failure risk. Not for routine use.36

Part 4: Recalibrating the System Without a Prescription

The most empowering discovery that emerges from the Autonomic Nervous System paradigm is this: medication is not the only way to adjust the thermostat.

In fact, some of the most powerful tools for recalibrating a dysregulated nervous system don’t come in a bottle.

They are behaviors and practices that we can learn and integrate into our daily lives.

When we view these practices through the lens of ANS regulation, they are elevated from vague “healthy habits” into targeted, potent, evidence-based medical interventions.

Subsection 4.1: Foundational Lifestyle Recalibration—Setting the Baseline

Before diving into specific techniques, it’s essential to establish a foundation of lifestyle choices that create an environment where the nervous system can find its balance.

These are not just suggestions; they are fundamental to restoring parasympathetic tone.

• Exercise Regularly: Physical activity is a powerful ANS modulator. Regular aerobic exercise (like walking, jogging, or cycling) can lower blood pressure by a significant 5 to 8 mm Hg.⁴² It acts, in effect, like a natural beta-blocker, slowing the resting heart rate and improving the heart’s efficiency.⁴³ Crucially, studies have shown that exercise interventions directly improve parasympathetic function. One key measure is Heart Rate Recovery (HRR)—how quickly your heart rate drops after peak exercise. Faster recovery indicates better parasympathetic (vagal) tone, and studies show that both exercise and diet interventions lead to significant improvements in HRR, which in turn predicts a reduction in blood pressure.²³ Aim for at least 30 minutes of moderate activity most days of the week, including strength training twice a week.⁴²
• Eat a Healthy Diet (The DASH Model): The Dietary Approaches to Stop Hypertension (DASH) diet is a well-researched eating plan proven to lower blood pressure.²³ It emphasizes fruits, vegetables, whole grains, and low-fat dairy while being low in sodium, saturated fat, and cholesterol.⁴⁵ The high potassium content of the DASH diet is particularly important, as potassium helps to lessen the effects of sodium on blood pressure.⁴² Research that combined the DASH diet with an exercise program found even greater improvements in ANS function and blood pressure than either intervention alone, underscoring the synergistic power of these lifestyle changes.²³
• Prioritize Sleep: Sleep is the prime time for the parasympathetic “rest-and-digest” system. It’s when the body performs its most critical repair and restoration work. It’s no surprise, then, that poor sleep is strongly linked to both increased anxiety and elevated blood pressure.³ To give your PNS the time it needs to function, it is vital to practice good sleep hygiene: stick to a regular schedule, create a cool, dark, and quiet environment, and avoid stimulants like caffeine and nicotine close to bedtime.⁴²
• Limit Alcohol: While a drink might feel relaxing in the moment, alcohol can be highly disruptive to the ANS. It can trigger symptoms of dysautonomia, interfere with the quality of sleep, and interact dangerously with both blood pressure and anxiety medications.²⁰

Subsection 4.2: Direct Autonomic Regulation—Manually Operating the Thermostat

Beyond these foundational habits, there are specific techniques that allow you to consciously and directly influence your autonomic state—to manually turn down the “heater” of the sympathetic system and activate the “idle mode” of the parasympathetic system.

• Controlled Breathwork: The link between our breath and our nervous system is direct and profound. The act of respiration is coupled neurologically with our heart rate and blood pressure.⁴⁶ In general, inhalation is linked to SNS activation (your heart rate slightly speeds up), while exhalation is linked to PNS activation (your heart rate slows down). By consciously controlling the pace and pattern of your breath, you can take manual control of your “thermostat.”

• Cyclic Sighing (The Physiological Sigh): This technique involves a double inhale through the nose (one long, followed by a shorter top-up breath) and a long, slow exhale through the mouth. Research has shown that just five minutes of this practice can significantly improve mood and reduce respiration rate, more so than mindfulness meditation, by offloading carbon dioxide and stimulating the vagus nerve—the main highway of the parasympathetic system.⁴⁶
• Box Breathing (Tactical Breathing): Used by military personnel and first responders to stay calm under pressure, this technique involves a simple, rhythmic pattern: inhale for a count of four, hold for four, exhale for four, and hold for four.⁴⁶ This steady rhythm helps to lower physiological arousal and prevent the SNS from spiraling into a full-blown panic response.
• Alternate Nostril Breathing: A technique from hatha yoga, this practice involves using a finger to close one nostril at a time while breathing. Research suggests that breathing predominantly through the left nostril can decrease blood pressure and activate the PNS, while breathing through the right can activate the SNS.⁴⁶ Practicing this can help regulate the entire system by balancing these two forces.
• Biofeedback and Heart Rate Variability (HRV) Training: This is where modern technology meets ancient wisdom. Biofeedback is a process of using electronic sensors to get real-time information about physiological processes that are normally unconscious, such as muscle tension, skin temperature, and, most importantly, heart rate and blood pressure.⁴⁷

• Heart Rate Variability (HRV) is a key metric in this field. It doesn’t measure your heart rate, but rather the tiny variations in time between each heartbeat. A high HRV is a sign of a healthy, resilient, and well-balanced ANS, indicating that your parasympathetic system is strong and can respond flexibly to challenges.⁴⁹ A low HRV is often associated with stress, anxiety, and cardiovascular disease.
• Using a biofeedback device (some of which are simple consumer wearables), you can get real-time feedback on your HRV. Through guided exercises, often involving paced breathing, you can learn to consciously increase your HRV.⁵⁰ This is, in essence, a workout for your parasympathetic nervous system. The FDA has even approved a biofeedback device called Resperate specifically for lowering blood pressure by guiding users into a state of slow, deep breathing.⁴⁸

These non-pharmacological interventions are not merely “complementary” therapies.

They are targeted, powerful methods for addressing the root cause of co-occurring anxiety and hypertension: a dysregulated autonomic nervous system.

A beta-blocker chemically blocks an adrenaline receptor to slow the heart.

A long, slow exhale stimulates the vagus nerve to release acetylcholine, which also slows the heart.

They are two different paths to the same physiological destination.

Recognizing this empowers you to become an active participant in your own healing, using tools you can access anytime, anywhere, to restore balance to your body’s master control system.

Part 5: Your Personalized Action Plan: Partnering With Your Doctor

The purpose of this deep dive into the science of the autonomic nervous system is not to encourage self-diagnosis or self-prescribing.

It is to transform you from a passive recipient of care into an informed, active, and empowered partner in your own health journey.

Armed with this new paradigm, you can have a fundamentally different, more productive conversation with your healthcare providers.

Moving from Patient to Partner: A New Kind of Conversation

Instead of simply reporting symptoms, you can now discuss the underlying system.

You can help your doctor connect the dots between your anxious mind and your hypertensive body, leading to a more holistic and synergistic treatment plan.

Here are some specific, paradigm-shifting questions you can bring to your next appointment:

• “I’ve been reading about the connection between the autonomic nervous system, anxiety, and high blood pressure. Given my symptoms, could we discuss the possibility that I’m experiencing a state of sympathetic overdrive or ANS dysregulation?”
• “When we choose a medication for my blood pressure, could we consider its potential impact on my mood? I’ve seen that drugs like ACE inhibitors or ARBs might be a better choice for me than beta-blockers, as they seem to have a lower risk of causing depression.”
• “Given my high blood pressure, I’m concerned that an SNRI antidepressant might raise it further because of its effect on norepinephrine. Could we start with an SSRI instead and monitor my blood pressure closely as we find the right dose?”
• “I want to take an active role in improving my parasympathetic tone. I’m going to start practicing daily controlled breathing exercises and tracking my Heart Rate Variability (HRV) with a wearable device. Can we make this an official part of my treatment plan and review the data together at our follow-up appointments?”

These questions reframe the conversation.

They show that you are thinking systemically and are committed to a comprehensive approach that includes both wise medication choices and active self-regulation.

The Goal is Resilience, Not Elimination

The final and most important takeaway is a reframing of the ultimate goal.

The objective is not to eliminate stress or anxiety from your life; that is an impossible and, frankly, undesirable task.

Stress is a part of a vibrant, engaged life.

The true goal is to build a resilient and flexible autonomic nervous system.

A resilient ANS is like a well-calibrated thermostat connected to an efficient HVAC system.

It can respond appropriately to challenges—turning on the “heat” of the sympathetic system when needed—but then, crucially, it can efficiently and effectively return to a calm, balanced, energy-conserving parasympathetic state once the challenge has passed.

The “best” treatment for co-occurring anxiety and high blood pressure, therefore, is not a single magic pill.

It is an integrated, personalized strategy that combines the most intelligent pharmacological choices—those that support ANS balance—with the daily, active practice of non-pharmacological techniques that strengthen and recalibrate this master regulatory system.

The journey is not about finding a cure that happens to you, but about becoming the conscious, skilled operator of your own physiology.

By understanding the system, you gain the power to change it.

Works cited

1. Effects of Anxiety on the Body – Healthline, accessed August 14, 2025, https://www.healthline.com/health/anxiety/effects-on-body
2. Comorbidity of Anxiety and Hypertension: Common Risk Factors and Potential Mechanisms, accessed August 14, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10234733/
3. The Link Between Anxiety and High Blood Pressure – UMMS Health, accessed August 14, 2025, https://health.umms.org/2022/10/27/anxiety-and-high-blood-pressure/
4. pmc.ncbi.nlm.nih.gov, accessed August 14, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC5573566/#:~:text=First%2Dline%20drugs%20are%20the,buspirone%2C%20moclobemide%2C%20and%20others.
5. Generalized anxiety disorder – Diagnosis and treatment – Mayo Clinic, accessed August 14, 2025, https://www.mayoclinic.org/diseases-conditions/generalized-anxiety-disorder/diagnosis-treatment/drc-20361045
6. Treatment of anxiety disorders – PMC, accessed August 14, 2025, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573566/
7. Anxiety Medication – HelpGuide.org, accessed August 14, 2025, https://www.helpguide.org/mental-health/anxiety/anxiety-medication
8. Sympathetic Nervous System (SNS): What It Is & Function – Cleveland Clinic, accessed August 14, 2025, https://my.clevelandclinic.org/health/body/23262-sympathetic-nervous-system-sns-fight-or-flight
9. Anxiety: A cause of high blood pressure? – Mayo Clinic, accessed August 14, 2025, https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/expert-answers/anxiety/faq-20058549
10. Both anxiety and high blood pressure affect many Americans | UCLA …, accessed August 14, 2025, https://www.uclahealth.org/news/article/both-anxiety-and-high-blood-pressure-affect-many-americans
11. Medications and supplements that can raise your blood pressure, accessed August 14, 2025, https://newsnetwork.mayoclinic.org/discussion/medications-and-supplements-that-can-raise-your-blood-pressure/
12. Medications may raise blood pressure| Express Scripts® Pharmacy, accessed August 14, 2025, https://www.express-scripts.com/pharmacy/blog/medications-may-raise-blood-pressure
13. Do Antidepressants Like Lexapro Raise Blood Pressure?, accessed August 14, 2025, https://www.verywellhealth.com/antidepressants-and-blood-pressure-1763988
14. High blood pressure (hypertension) – Diagnosis & treatment – Mayo Clinic, accessed August 14, 2025, https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/diagnosis-treatment/drc-20373417
15. Beta blockers – Mayo Clinic, accessed August 14, 2025, https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/beta-blockers/art-20044522
16. Blood pressure drugs may affect mood disorders | The BMJ, accessed August 14, 2025, https://www.bmj.com/content/355/bmj.i5460
17. Drugs That Cause Depression – WebMD, accessed August 14, 2025, https://www.webmd.com/depression/medicines-cause-depression
18. The relationship between antihypertensive medications and mood disorders: analysis of linked healthcare data for 1.8 million patients – PubMed Central, accessed August 14, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8188528/
19. An Introduction to Feedback Loops – Farnam Street, accessed August 14, 2025, https://fs.blog/mental-model-feedback-loops/
20. Dysautonomia: What It Is, Symptoms, Types & Treatment – Cleveland Clinic, accessed August 14, 2025, https://my.clevelandclinic.org/health/diseases/6004-dysautonomia
21. Dysautonomia: Causes, Symptoms and Treatments, accessed August 14, 2025, https://thedysautonomiaproject.org/dysautonomia/
22. The Autonomic Nervous System’s Dynamic Role in Blood Pressure Regulation: Insights from Physiological and Pathological States. | European Journal of Cardiovascular Medicine, accessed August 14, 2025, https://healthcare-bulletin.co.uk/article/the-autonomic-nervous-system-s-dynamic-role-in-blood-pressure-regulation-insights-from-physiological-and-pathological-states–2591/
23. Effects on blood pressure and autonomic nervous system function of a 12-week exercise or exercise plus DASH-diet intervention in individuals with elevated blood pressure, accessed August 14, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC3192938/
24. Stress and high blood pressure: What’s the connection? – Mayo Clinic, accessed August 14, 2025, https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/stress-and-high-blood-pressure/art-20044190
25. The Autonomic Nervous System and Hypertension | Circulation …, accessed August 14, 2025, https://www.ahajournals.org/doi/10.1161/circresaha.114.302524
26. Autonomic imbalance, hypertension, and cardiovascular risk – Oxford Academic, accessed August 14, 2025, https://academic.oup.com/ajh/article/13/S4/112S/186277
27. Anxiety, depression and autonomic nervous system dysfunction in …, accessed August 14, 2025, https://pubmed.ncbi.nlm.nih.gov/22425019/
28. Beta-Blockers for Anxiety: Benefits, Side Effects, and Risks – Healthline, accessed August 14, 2025, https://www.healthline.com/health/beta-blockers-for-anxiety
29. Beta-Blockers: Uses & Side Effects – Cleveland Clinic, accessed August 14, 2025, https://my.clevelandclinic.org/health/treatments/22318-beta-blockers
30. Propranolol: medicine for heart problems, anxiety and migraine – NHS, accessed August 14, 2025, https://www.nhs.uk/medicines/propranolol/
31. This Common Heart Medication May Ease Anxiety | Cedars-Sinai, accessed August 14, 2025, https://www.cedars-sinai.org/blog/this-common-heart-medication-may-ease-anxiety.html
32. Beta Blockers Are a Buzzy New Anti-Anxiety Medicine, Here’s What …, accessed August 14, 2025, https://www.verywellmind.com/beta-blockers-are-the-buzzy-new-anti-anxiety-medicine-heres-what-you-need-to-know-5271756
33. Can Beta Blockers Help With Anxiety? Here’s What to Know | University Hospitals, accessed August 14, 2025, https://www.uhhospitals.org/blog/articles/2025/06/can-beta-blockers-help-with-anxiety-heres-what-to-know
34. Can Beta Blockers Treat Anxiety? How They Manage Symptoms – GoodRx, accessed August 14, 2025, https://www.goodrx.com/classes/beta-blockers/can-beta-blockers-treat-anxiety
35. What It’s Like to Take Propranolol For Anxiety | Blog | YoungMinds, accessed August 14, 2025, https://www.youngminds.org.uk/young-person/blog/what-it-s-like-to-take-propranolol-for-anxiety/
36. Alpha-Blockers – StatPearls – NCBI Bookshelf, accessed August 14, 2025, https://www.ncbi.nlm.nih.gov/books/NBK556066/
37. Alpha blockers – Mayo Clinic, accessed August 14, 2025, https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/alpha-blockers/art-20044214
38. Alpha-blockers are a type of medicine that can be used to treat high blood pressure., accessed August 14, 2025, https://www.bloodpressureuk.org/your-blood-pressure/how-to-lower-your-blood-pressure/medications-for-high-blood-pressure/alpha-blockers/
39. Centrally acting antihypertensives and alpha-blockers in people at risk of falls: therapeutic dilemmas—a clinical review, accessed August 14, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10447259/
40. Alpha blocker – Wikipedia, accessed August 14, 2025, https://en.wikipedia.org/wiki/Alpha_blocker
41. Antihypertensive Medications – StatPearls – NCBI Bookshelf, accessed August 14, 2025, https://www.ncbi.nlm.nih.gov/books/NBK554579/
42. 10 ways to control high blood pressure without medication – Mayo Clinic, accessed August 14, 2025, https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/high-blood-pressure/art-20046974
43. Natural Ways to Lower Blood Pressure | Johns Hopkins Medicine, accessed August 14, 2025, https://www.hopkinsmedicine.org/health/conditions-and-diseases/high-blood-pressure-hypertension/natural-ways-to-lower-blood-pressure
44. Effects on blood pressure and autonomic nervous system function of …, accessed August 14, 2025, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192938/
45. High Blood Pressure (Hypertension) (Holistic) – Health Information Library | PeaceHealth, accessed August 14, 2025, https://www.peacehealth.org/medical-topics/id/hn-1033009
46. What is Nervous System Regulation & Why is it Important?, accessed August 14, 2025, https://positivepsychology.com/nervous-system-regulation/
47. Biofeedback | Johns Hopkins Medicine, accessed August 14, 2025, https://www.hopkinsmedicine.org/health/wellness-and-prevention/biofeedback
48. Biofeedback – Mayo Clinic, accessed August 14, 2025, https://www.mayoclinic.org/tests-procedures/biofeedback/about/pac-20384664
49. ANS Regulation Techniques | Center for Mindful Therapy, accessed August 14, 2025, https://mindfulcenter.org/ans-regulation-techniques/
50. Unlock the Autonomic Nervous System: How PTs Help Patients Achieve Optimal Health, accessed August 14, 2025, https://neupttech.com/blog/unlock-the-power-of-the-autonomic-nervous-system-how-pts-help-patients-achieve-optimal-health